DIAGNOSTIC REPORT
MC-6469
PATIENT NAME : SUSHILA SINGH REF. DOCTOR : DR. MANJARI DWIVEDI
CODE/NAME & ADDRESS : C000140248 ACCESSION NO : 0024YB000178 AGE/SEX : 62 Years Female
RX MEDICALS COLLECTION CENTRE PATIENT ID : SUSHF220119630 DRAWN : 01/02/2025 [Link]
GF-01 GALAXY TOWER, VIJAYANT KHAND GOMTI
CLIENT PATIENT ID: RECEIVED : 01/02/2025 [Link]
NAGAR,LUCKNOW
ABHA NO : REPORTED : 01/02/2025 [Link]
LUCKNOW 226010
9336315148
Test Report Status Final Results Biological Reference Interval Units
BIOCHEMISTRY
GLUCOSE FASTING,FLUORIDE PLASMA
FBS (FASTING BLOOD SUGAR) 118 High mg/dL
(Normal <100,Impaired fasting
glucose:100 to 125,Diabetes
mellitus:>=126(on more than
1 occasion)(ADA guidelines
2024)
METHOD : HEXOKINASE
GLUCOSE, POST-PRANDIAL, PLASMA
PPBS(POST PRANDIAL BLOOD SUGAR) 160 High Non-Diabetes mg/dL
70 - 140
METHOD : HEXOKINASE
Page 1 Of 3
[Link] Tiwari, MBBS, DNB
(Pathology),([Link]. UPMC -
58080)
Lab Head
View Details View Report
PERFORMED AT :
Agilus Diagnostics Ltd
C-3/282,Vipul Khand, Gomtinagar
Lucknow, 226010 ULR No.775000011018995-0024
Uttar Pradesh, India
Tel : 9111591115, Fax : 0522 - 406 2980
CIN - U74899PB1995PLC045956
Email : [Link]@[Link]
DIAGNOSTIC REPORT
MC-6469
PATIENT NAME : SUSHILA SINGH REF. DOCTOR : DR. MANJARI DWIVEDI
CODE/NAME & ADDRESS : C000140248 ACCESSION NO : 0024YB000178 AGE/SEX : 62 Years Female
RX MEDICALS COLLECTION CENTRE PATIENT ID : SUSHF220119630 DRAWN : 01/02/2025 [Link]
GF-01 GALAXY TOWER, VIJAYANT KHAND GOMTI
CLIENT PATIENT ID: RECEIVED : 01/02/2025 [Link]
NAGAR,LUCKNOW
ABHA NO : REPORTED : 01/02/2025 [Link]
LUCKNOW 226010
9336315148
Test Report Status Final Results Biological Reference Interval Units
Interpretation(s)
GLUCOSE FASTING,FLUORIDE PLASMA-TEST DESCRIPTION
Normally, the glucose concentration in extracellular fluid is closely regulated so that a source of energy is readily available to tissues and sothat no glucose is excreted in the
urine.
Increased in:Diabetes mellitus, Cushing’ s syndrome (10 – 15%), chronic pancreatitis (30%). Drugs:corticosteroids,phenytoin, estrogen, thiazides.
Decreased in :Pancreatic islet cell disease with increased insulin,insulinoma,adrenocortical insufficiency,hypopituitarism,diffuse liver disease,
malignancy(adrenocortical,stomach,fibrosarcoma),infant of a diabetic mother,enzyme deficiency diseases([Link]),Drugs-insulin,ethanol,propranolol
sulfonylureas,tolbutamide,and other oral hypoglycemic agents.
NOTE: While random serum glucose levels correlate with home glucose monitoring results (weekly mean capillary glucose values),there is wide fluctuation within
[Link], glycosylated hemoglobin(HbA1c) levels are favored to monitor glycemic control.
High fasting glucose level in comparison to post prandial glucose level may be seen due to effect of Oral Hypoglycaemics & Insulin treatment,Renal Glyosuria,Glycaemic
index & response to food consumed,Alimentary Hypoglycemia,Increased insulin response & sensitivity etc.
GLUCOSE, POST-PRANDIAL, PLASMA-High fasting glucose level in comparison to post prandial glucose level may be seen due to effect of Oral Hypoglycaemics & Insulin
treatment, Renal Glyosuria, Glycaemic index & response to food consumed, Alimentary Hypoglycemia, Increased insulin response & sensitivity [Link] test HbA1c
**End Of Report**
Please visit [Link] for related Test Information for this accession
Page 2 Of 3
[Link] Tiwari, MBBS, DNB
(Pathology),([Link]. UPMC -
58080)
Lab Head
View Details View Report
PERFORMED AT :
Agilus Diagnostics Ltd
C-3/282,Vipul Khand, Gomtinagar
Lucknow, 226010 ULR No.775000011018995-0024
Uttar Pradesh, India
Tel : 9111591115, Fax : 0522 - 406 2980
CIN - U74899PB1995PLC045956
Email : [Link]@[Link]
DIAGNOSTIC REPORT
MC-6469
PATIENT NAME : SUSHILA SINGH REF. DOCTOR : DR. MANJARI DWIVEDI
CODE/NAME & ADDRESS : C000140248 ACCESSION NO : 0024YB000178 AGE/SEX : 62 Years Female
RX MEDICALS COLLECTION CENTRE PATIENT ID : SUSHF220119630 DRAWN : 01/02/2025 [Link]
GF-01 GALAXY TOWER, VIJAYANT KHAND GOMTI
CLIENT PATIENT ID: RECEIVED : 01/02/2025 [Link]
NAGAR,LUCKNOW
ABHA NO : REPORTED : 01/02/2025 [Link]
LUCKNOW 226010
9336315148
Test Report Status Final Results Biological Reference Interval Units
CONDITIONS OF LABORATORY TESTING & REPORTING
1. It is presumed that the test sample belongs to the patient 5. AGILUS Diagnostics confirms that all tests have been
named or identified in the test requisition form. performed or assayed with highest quality standards, clinical
2. All tests are performed and reported as per the safety & technical integrity.
turnaround time stated in the AGILUS Directory of Services. 6. Laboratory results should not be interpreted in isolation;
3. Result delays could occur due to unforeseen it must be correlated with clinical information and be
circumstances such as non-availability of kits / equipment interpreted by registered medical practitioners only to
breakdown / natural calamities / technical downtime or any determine final diagnosis.
other unforeseen event. 7. Test results may vary based on time of collection,
4. A requested test might not be performed if: physiological condition of the patient, current medication or
i. Specimen received is insufficient or inappropriate nutritional and dietary changes. Please consult your doctor
ii. Specimen quality is unsatisfactory or call us for any clarification.
iii. Incorrect specimen type 8. Test results cannot be used for Medico legal purposes.
iv. Discrepancy between identification on specimen 9. In case of queries please call customer care
container label and test requisition form (91115 91115) within 48 hours of the report.
.
Agilus Diagnostics Ltd
Fortis Hospital, Sector 62, Phase VIII,
Mohali 160062
Page 3 Of 3
[Link] Tiwari, MBBS, DNB
(Pathology),([Link]. UPMC -
58080)
Lab Head
View Details View Report
PERFORMED AT :
Agilus Diagnostics Ltd
C-3/282,Vipul Khand, Gomtinagar
Lucknow, 226010 ULR No.775000011018995-0024
Uttar Pradesh, India
Tel : 9111591115, Fax : 0522 - 406 2980
CIN - U74899PB1995PLC045956
Email : [Link]@[Link]
